Odomi M - Search Results

1

Biotransformation of the novel inotropic agent toborinone (OPC-18790) in rats and dogs. Evidence for the formation of novel glutathione and two cysteine conjugates.

Kitani M, Miyamoto G, Nagasawa M, Yamada T, Matsubara J, Uchida M, Odomi M. Kitani M, et al. Among authors: odomi m. Drug Metab Dispos. 1997 Jun;25(6):663-74. Drug Metab Dispos. 1997. PMID: 9193867

2

Metabolism of 1-(3,4-dichlorobenzyl)-5-octylbiguanide in the dog.

Kudo S, Umehara K, Morita S, Uchida M, Miyamoto G, Odomi M. Kudo S, et al. Among authors: odomi m. Xenobiotica. 1998 May;28(5):507-14. doi: 10.1080/004982598239425. Xenobiotica. 1998. PMID: 9622852

3

Oxidative cleavage of the octyl side chain of 1-(3,4-dichlorobenzyl)-5-octylbiguanide (OPB-2045) in rat and dog liver preparations.

Umehara K, Kudo S, Hirao Y, Morita S, Uchida M, Odomi M, Miyamoto G. Umehara K, et al. Among authors: odomi m. Drug Metab Dispos. 2000 Aug;28(8):887-94. Drug Metab Dispos. 2000. PMID: 10901696

4

Stereoselective high-performance liquid chromatographic assay for the determination of OPC-18790 enantiomers in human plasma and urine.

Kitani M, Miyamoto G, Odomi M. Kitani M, et al. Among authors: odomi m. J Chromatogr. 1993 Oct 22;620(1):97-104. doi: 10.1016/0378-4347(93)80056-a. J Chromatogr. 1993. PMID: 8106598

5

Metabolism of carteolol by cDNA-expressed human cytochrome P450.

Kudo S, Uchida M, Odomi M. Kudo S, et al. Among authors: odomi m. Eur J Clin Pharmacol. 1997;52(6):479-85. doi: 10.1007/s002280050322. Eur J Clin Pharmacol. 1997. PMID: 9342584

6

High-performance liquid chromatography-electrospray tandem mass spectrometry for the measurement of 1-(3,4-dichlorobenzyl)-5-octylbiguanide in human serum.

Kudo S, Mizooku Y, Miyamoto G, Odomi M, Sogawa Y, Sugai T. Kudo S, et al. Among authors: odomi m. Ther Drug Monit. 1998 Dec;20(6):697-705. doi: 10.1097/00007691-199812000-00021. Ther Drug Monit. 1998. PMID: 9853991

7

High-performance liquid chromatographic procedure for the determination of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-(dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone, in human plasma and urine.

Miyamoto G, Sasabe H, Odomi M, Shimizu T. Miyamoto G, et al. Among authors: odomi m. J Chromatogr. 1985 Mar 22;338(2):450-5. doi: 10.1016/0378-4347(85)80120-1. J Chromatogr. 1985. PMID: 3998030 No abstract available.

8

Pharmacokinetics, safety, and pharmacologic effects of OPC-21268, a nonpeptide orally active vasopressin V1 receptor antagonist, in humans.

Ohnishi A, Ko Y, Fujihara H, Miyamoto G, Okada K, Odomi M. Ohnishi A, et al. Among authors: odomi m. J Clin Pharmacol. 1993 Mar;33(3):230-8. doi: 10.1002/j.1552-4604.1993.tb03949.x. J Clin Pharmacol. 1993. PMID: 8385161 Clinical Trial.

9

Cytochrome P450 responsible for the stereoselective S-oxidation of flosequinan in hepatic microsomes from rats and humans.

Kashiyama E, Yokoi T, Odomi M, Funae Y, Inoue K, Kamataki T. Kashiyama E, et al. Among authors: odomi m. Drug Metab Dispos. 1997 Jun;25(6):716-24. Drug Metab Dispos. 1997. PMID: 9193873

10

Chronic corticosteroid administration causes mitochondrial dysfunction in skeletal muscle.

Mitsui T, Azuma H, Nagasawa M, Iuchi T, Akaike M, Odomi M, Matsumoto T. Mitsui T, et al. Among authors: odomi m. J Neurol. 2002 Aug;249(8):1004-9. doi: 10.1007/s00415-002-0774-5. J Neurol. 2002. PMID: 12195445

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters